Synexus recognises the unique challenges of oncology trials throughout research, symptom control and cancer survivors. In a complex and constantly evolving cancer research environment, Synexus has the experienced professionals and in-depth understanding of the latest regulatory developments and access to the most innovative and cutting-edge technologies in oncology research. Providing you with the valuable insight that will make a critical difference in the outcome of your next oncology trial.

Areas of expertise include

  • Breast cancer
  • Cancer vaccine therapy
  • Colon cancer
  • Gene-targeted therapy
  • Immunotherapy
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Melanoma
  • Prostate cancer
  • Rare-disease compounds
  • Sarcoma
  • Virus vector